ES2527527T3 - Composiciones basadas en aminoácidos de cadena ramificada para mejorar la función ventricular miocárdica en pacientes que padecen diabetes - Google Patents
Composiciones basadas en aminoácidos de cadena ramificada para mejorar la función ventricular miocárdica en pacientes que padecen diabetes Download PDFInfo
- Publication number
- ES2527527T3 ES2527527T3 ES02735773.0T ES02735773T ES2527527T3 ES 2527527 T3 ES2527527 T3 ES 2527527T3 ES 02735773 T ES02735773 T ES 02735773T ES 2527527 T3 ES2527527 T3 ES 2527527T3
- Authority
- ES
- Spain
- Prior art keywords
- diabetes
- chain amino
- patients suffering
- amino acid
- branched chain
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- 150000005693 branched-chain amino acids Chemical class 0.000 title abstract 3
- 206010012601 diabetes mellitus Diseases 0.000 title abstract 2
- 239000000203 mixture Substances 0.000 title abstract 2
- 230000002107 myocardial effect Effects 0.000 title 1
- 230000002861 ventricular Effects 0.000 title 1
- HNDVDQJCIGZPNO-YFKPBYRVSA-N L-histidine Chemical compound OC(=O)[C@@H](N)CC1=CN=CN1 HNDVDQJCIGZPNO-YFKPBYRVSA-N 0.000 abstract 2
- FFEARJCKVFRZRR-BYPYZUCNSA-N L-methionine Chemical compound CSCC[C@H](N)C(O)=O FFEARJCKVFRZRR-BYPYZUCNSA-N 0.000 abstract 2
- COLNVLDHVKWLRT-QMMMGPOBSA-N L-phenylalanine Chemical compound OC(=O)[C@@H](N)CC1=CC=CC=C1 COLNVLDHVKWLRT-QMMMGPOBSA-N 0.000 abstract 2
- QIVBCDIJIAJPQS-VIFPVBQESA-N L-tryptophane Chemical compound C1=CC=C2C(C[C@H](N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-VIFPVBQESA-N 0.000 abstract 2
- KDXKERNSBIXSRK-UHFFFAOYSA-N Lysine Natural products NCCCCC(N)C(O)=O KDXKERNSBIXSRK-UHFFFAOYSA-N 0.000 abstract 2
- 239000004472 Lysine Substances 0.000 abstract 2
- AYFVYJQAPQTCCC-UHFFFAOYSA-N Threonine Natural products CC(O)C(N)C(O)=O AYFVYJQAPQTCCC-UHFFFAOYSA-N 0.000 abstract 2
- 239000004473 Threonine Substances 0.000 abstract 2
- QIVBCDIJIAJPQS-UHFFFAOYSA-N Tryptophan Natural products C1=CC=C2C(CC(N)C(O)=O)=CNC2=C1 QIVBCDIJIAJPQS-UHFFFAOYSA-N 0.000 abstract 2
- HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 abstract 2
- 229930182817 methionine Natural products 0.000 abstract 2
- COLNVLDHVKWLRT-UHFFFAOYSA-N phenylalanine Natural products OC(=O)C(N)CC1=CC=CC=C1 COLNVLDHVKWLRT-UHFFFAOYSA-N 0.000 abstract 2
- LEVWYRKDKASIDU-QWWZWVQMSA-N D-cystine Chemical compound OC(=O)[C@H](N)CSSC[C@@H](N)C(O)=O LEVWYRKDKASIDU-QWWZWVQMSA-N 0.000 abstract 1
- 206010019280 Heart failures Diseases 0.000 abstract 1
- XUJNEKJLAYXESH-REOHCLBHSA-N L-Cysteine Chemical compound SC[C@H](N)C(O)=O XUJNEKJLAYXESH-REOHCLBHSA-N 0.000 abstract 1
- AGPKZVBTJJNPAG-WHFBIAKZSA-N L-isoleucine Chemical compound CC[C@H](C)[C@H](N)C(O)=O AGPKZVBTJJNPAG-WHFBIAKZSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-YFKPBYRVSA-N L-leucine Chemical compound CC(C)C[C@H](N)C(O)=O ROHFNLRQFUQHCH-YFKPBYRVSA-N 0.000 abstract 1
- KDXKERNSBIXSRK-YFKPBYRVSA-N L-lysine Chemical compound NCCCC[C@H](N)C(O)=O KDXKERNSBIXSRK-YFKPBYRVSA-N 0.000 abstract 1
- AYFVYJQAPQTCCC-GBXIJSLDSA-N L-threonine Chemical compound C[C@@H](O)[C@H](N)C(O)=O AYFVYJQAPQTCCC-GBXIJSLDSA-N 0.000 abstract 1
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-BYPYZUCNSA-N L-valine Chemical compound CC(C)[C@H](N)C(O)=O KZSNJWFQEVHDMF-BYPYZUCNSA-N 0.000 abstract 1
- ROHFNLRQFUQHCH-UHFFFAOYSA-N Leucine Natural products CC(C)CC(N)C(O)=O ROHFNLRQFUQHCH-UHFFFAOYSA-N 0.000 abstract 1
- KZSNJWFQEVHDMF-UHFFFAOYSA-N Valine Natural products CC(C)C(N)C(O)=O KZSNJWFQEVHDMF-UHFFFAOYSA-N 0.000 abstract 1
- 239000004480 active ingredient Substances 0.000 abstract 1
- XUJNEKJLAYXESH-UHFFFAOYSA-N cysteine Natural products SCC(N)C(O)=O XUJNEKJLAYXESH-UHFFFAOYSA-N 0.000 abstract 1
- 235000018417 cysteine Nutrition 0.000 abstract 1
- 229960003067 cystine Drugs 0.000 abstract 1
- AGPKZVBTJJNPAG-UHFFFAOYSA-N isoleucine Natural products CCC(C)C(N)C(O)=O AGPKZVBTJJNPAG-UHFFFAOYSA-N 0.000 abstract 1
- 229960000310 isoleucine Drugs 0.000 abstract 1
- 238000004519 manufacturing process Methods 0.000 abstract 1
- 208000001072 type 2 diabetes mellitus Diseases 0.000 abstract 1
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 abstract 1
- 239000004474 valine Substances 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl groups being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid or pantothenic acid
- A61K31/198—Alpha-amino acids, e.g. alanine or edetic acid [EDTA]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/04—Inotropic agents, i.e. stimulants of cardiac contraction; Drugs for heart failure
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Cardiology (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Diabetes (AREA)
- Heart & Thoracic Surgery (AREA)
- Hospice & Palliative Care (AREA)
- Endocrinology (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Emergency Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
Uso de los aminoácidos de cadena ramificada leucina, isoleucina y valina, en combinación con treonina, lisina, metionina, fenilalanina, histidina, triptófano, tirosina, cisteína y cistina como principios activos para la fabricación de composiciones para retardar o prevenir la insuficiencia cardiaca en pacientes que padecen diabetes, particularmente pero no exclusivamente diabetes de tipo II, en el que la suma de las cantidades en pesos moleculares de treonina y lisina es mayor que la suma de las cantidades de metionina, fenilalanina, histidina, triptófano que se proporcionan, pero menor que la suma de las cantidades de dichos aminoácidos de cadena ramificada.
Description
Claims (1)
-
imagen1
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
ITTO20010580 | 2001-06-15 | ||
IT2001TO000580A ITTO20010580A1 (it) | 2001-06-15 | 2001-06-15 | Composizioni a base di aminoacidi per il miglioramento della funzioneventricolare miocardica in pazienti affetti da diabete. |
PCT/IB2002/002149 WO2002102360A2 (en) | 2001-06-15 | 2002-06-10 | Compositions based on branched chain amino acids for improving the myocardial ventricular function in patients suffering from diabetes |
Publications (1)
Publication Number | Publication Date |
---|---|
ES2527527T3 true ES2527527T3 (es) | 2015-01-26 |
Family
ID=11458964
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
ES02735773.0T Expired - Lifetime ES2527527T3 (es) | 2001-06-15 | 2002-06-10 | Composiciones basadas en aminoácidos de cadena ramificada para mejorar la función ventricular miocárdica en pacientes que padecen diabetes |
Country Status (12)
Country | Link |
---|---|
US (2) | US20040157903A1 (es) |
EP (1) | EP1399139B1 (es) |
JP (1) | JP4364632B2 (es) |
KR (1) | KR100894365B1 (es) |
AU (1) | AU2002309122A1 (es) |
CA (1) | CA2448745C (es) |
CY (1) | CY1115918T1 (es) |
DK (1) | DK1399139T3 (es) |
ES (1) | ES2527527T3 (es) |
IT (1) | ITTO20010580A1 (es) |
PT (1) | PT1399139E (es) |
WO (1) | WO2002102360A2 (es) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ITTO20030789A1 (it) * | 2003-10-07 | 2005-04-08 | Professional Dietetics Srl | Composizione a base di amino acidi per il trattamento |
EP1537865A1 (de) * | 2003-12-03 | 2005-06-08 | Franz-Peter Dr. Liebel | Verwendung von schwefelhaltigen Verbindungen und proteolytischen Enzymen zur Prophylaxe und Therapie des UDP-Glucuronosyl-transferase 1-defizitären Diabetes mellitus Typ II |
EP1537864A1 (de) * | 2003-12-03 | 2005-06-08 | Franz-Peter Dr. Liebel | Verwendung von Aminosäuren und schwefeltragenden Verbindungen zur Prophylaxe und Therapie des UDP-Glucuronosyltransferase1-defizitären Diabetes mellitus Typ II |
US20080032915A1 (en) * | 2004-02-12 | 2008-02-07 | Campina Nederland Holding B.V. | Cysteine Rich Peptides for Improving Thiol Homeostasis |
JP2008056566A (ja) * | 2004-12-28 | 2008-03-13 | Toudai Tlo Ltd | 低酸素応答促進剤 |
JP2009536016A (ja) * | 2006-01-20 | 2009-10-08 | インエル ビョルク, | アミノ酸を含む食品組成物 |
KR101487852B1 (ko) * | 2006-12-15 | 2015-01-29 | 티마 파운데이션 | 신규조성물 및 그 용도 |
US8633192B2 (en) | 2006-12-15 | 2014-01-21 | Tima Foundation | Compositions and uses thereof |
US8795973B2 (en) * | 2010-11-29 | 2014-08-05 | University of Leceister | Methods for identifying inhibitors of mannan-binding lectin associated serine protease (MASP) proteins and uses thereof |
JOP20190146A1 (ar) | 2016-12-19 | 2019-06-18 | Axcella Health Inc | تركيبات حمض أميني وطرق لمعالجة أمراض الكبد |
IT201700087359A1 (it) | 2017-07-28 | 2019-01-28 | Professional Dietetics Spa | Composizioni comprendenti amino acidi per l'uso nel trattamento di malattie associate a disfunzione mitocondriale |
PE20200747A1 (es) | 2017-08-14 | 2020-07-24 | Axcella Health Inc | Composiciones de aminoacidos para el tratamiento de enfermedad hepatica |
MA52971A (fr) | 2018-06-20 | 2021-04-28 | Axcella Health Inc | Compositions et procédés pour le traitement de l'infiltration de graisse dans le muscle |
Family Cites Families (10)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4053589A (en) * | 1975-11-24 | 1977-10-11 | Control Drug Inc. | Method of treating nutritional deficiency during cardiac cachexia, diabetes, hypoglycemia, gastroenterology, lipid, cell glycogen and keratin-related skin conditions and alcoholism |
JPS60255722A (ja) | 1984-05-30 | 1985-12-17 | Otsuka Pharmaceut Factory Inc | 糖尿病用アミノ酸輸液 |
US5032608A (en) * | 1986-09-10 | 1991-07-16 | Dudrick Stanley J | Method and substrate composition for treating atherosclerosis |
US5132113A (en) * | 1990-10-26 | 1992-07-21 | Maurizio Luca | Nutritional composition containing essential amino acids |
AU655780B2 (en) * | 1990-10-30 | 1995-01-12 | Clintec Nutrition Company | A method and composition for the protection of a metabolic recovery of ischemic cardiac tissue |
US5276018A (en) * | 1992-07-17 | 1994-01-04 | Brigham And Women's Hospital | Composition comprising amino acids and methods for decreasing muscle breakdown |
LU88369A1 (fr) * | 1993-07-12 | 1994-04-01 | Michel Urso Prof Medecin Et Ch | Acides aminés à chaînes ramifiées |
IT1289754B1 (it) | 1996-12-16 | 1998-10-16 | Professional Dietetics Srl | Composizioni a base di aminoacidi |
IT1320782B1 (it) * | 2000-07-04 | 2003-12-10 | Professional Dietetics Srl | Composizioni a base di aminoacidi, atte al trattamentodell'insufficienza cardiaca. |
IT1320783B1 (it) * | 2000-07-04 | 2003-12-10 | Professional Dietetics Srl | Composizioni a base di aminoacidi, atte al miglioramento delleprestazioni muscolari. |
-
2001
- 2001-06-15 IT IT2001TO000580A patent/ITTO20010580A1/it unknown
-
2002
- 2002-06-10 ES ES02735773.0T patent/ES2527527T3/es not_active Expired - Lifetime
- 2002-06-10 CA CA2448745A patent/CA2448745C/en not_active Expired - Fee Related
- 2002-06-10 DK DK02735773.0T patent/DK1399139T3/en active
- 2002-06-10 JP JP2003504947A patent/JP4364632B2/ja not_active Expired - Fee Related
- 2002-06-10 PT PT2735773T patent/PT1399139E/pt unknown
- 2002-06-10 WO PCT/IB2002/002149 patent/WO2002102360A2/en active Application Filing
- 2002-06-10 KR KR1020037016184A patent/KR100894365B1/ko not_active IP Right Cessation
- 2002-06-10 EP EP02735773.0A patent/EP1399139B1/en not_active Expired - Lifetime
- 2002-06-10 US US10/480,774 patent/US20040157903A1/en not_active Abandoned
- 2002-06-10 AU AU2002309122A patent/AU2002309122A1/en not_active Abandoned
-
2008
- 2008-04-17 US US12/104,722 patent/US8653136B2/en not_active Expired - Fee Related
-
2015
- 2015-01-12 CY CY20151100027T patent/CY1115918T1/el unknown
Also Published As
Publication number | Publication date |
---|---|
KR100894365B1 (ko) | 2009-04-22 |
EP1399139A2 (en) | 2004-03-24 |
JP2004534073A (ja) | 2004-11-11 |
KR20040008217A (ko) | 2004-01-28 |
JP4364632B2 (ja) | 2009-11-18 |
EP1399139B1 (en) | 2014-10-15 |
CA2448745A1 (en) | 2002-12-27 |
CA2448745C (en) | 2012-09-04 |
CY1115918T1 (el) | 2017-01-25 |
DK1399139T3 (en) | 2015-01-12 |
WO2002102360A2 (en) | 2002-12-27 |
US20080194665A1 (en) | 2008-08-14 |
WO2002102360A3 (en) | 2003-05-30 |
AU2002309122A1 (en) | 2003-01-02 |
US20040157903A1 (en) | 2004-08-12 |
ITTO20010580A1 (it) | 2002-12-15 |
US8653136B2 (en) | 2014-02-18 |
PT1399139E (pt) | 2015-01-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ES2527527T3 (es) | Composiciones basadas en aminoácidos de cadena ramificada para mejorar la función ventricular miocárdica en pacientes que padecen diabetes | |
ES2512141T3 (es) | Análogo peptídico de oxintomodulina | |
AR105485A1 (es) | Derivado de glucagón y una composición que comprende un conjugado de acción prolongada del mismo | |
Shive et al. | An interrelationship of thymidine and vitamin B12 | |
CY1110941T1 (el) | Συνθεση πολυπεπτιου hip/pap για χρηση σε αναζωογονηση ηπατος και για την αποτροπη ηπατικης ανεπαρκειας | |
BRPI0417684A (pt) | composto, composição farmacêutica, e, uso de um composto | |
EA200901365A1 (ru) | Стабилизированная фармацевтическая композиция, содержащая прегабалин | |
PE20030802A1 (es) | Formas de dosificacion de liberacion inmediata que contienen dispersiones de farmaco solido | |
ES2494316T3 (es) | Ingrediente activo novedoso en cicatrización y uso del mismo | |
AR039170A1 (es) | Co-granulos de dha y romero y metodos de uso | |
ES2507094T3 (es) | Proteína específica del timo | |
KR910014103A (ko) | 사람의 손톱 처리용 국소 제제 | |
EP1374863A4 (en) | AMINO ACID COMPOSITIONS USED TO IMPROVE HEPATIC INSUFFICIENCY | |
EA200401111A1 (ru) | Биполярные соли транс-каротиноидов и их применение | |
RU2010111139A (ru) | Комбинированная терапия рака поджелудочной железы с использованием антигенного пептида и химиотерапевтического средства | |
JP2004534073A5 (es) | ||
DE60227670D1 (de) | Aminosäuren-enthaltende zusammensetzungen, geeignet zur wundheilung, insbesondere zur behandlung des auges | |
ES2542227T3 (es) | Tratamiento de complicaciones vasculares de diabetes | |
KR890003409A (ko) | 점막 투여시 흡수 촉진제로서의 시클릭 펩티드 | |
ATE487390T1 (de) | Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs | |
CR7058A (es) | Peptidos humanos sinteticos y composiciones farmaceuticas que los contienen para el tratamiento de lupus eritematoso sistemico | |
BR9910936A (pt) | Preparações aquosas semi-sólidas para a aplicação oral de toltrazuril-sulfona | |
EA200401334A1 (ru) | Фармацевтические композиции карбидопы и леводопы с контролируемым высвобождением | |
TR200402654T4 (tr) | Kalp yetmezliğinin tedavisine uygun, aminoasitlere dayanan kompozisyonlar | |
ES2177769T3 (es) | Derivado de aminotetralina para la terapia de trastornos cardiovascu lares. |